Autres langues TrivarX Limited

Actions

TRI

AU0000300196

Cours en clôture Australian S.E. Autres places de cotation 00:00:00 15/05/2024			Varia. 5j.	Varia. 1 janv.
0,028 ^AUD	+7,69%		-12,50%	-6,67%

02/05	TrivarX reçoit des engagements fermes pour une émission d'actions de 2,5 millions de dollars australiens ; les actions bondissent de 27%.	MT
28/02	TrivarX Limited publie ses résultats pour le semestre clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

TrivarX Receives Firm Commitments for AU$2.5 Million Share Issuance; Shares Jump 27%	02/05
TrivarX Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28/02
TrivarX Signs Collaboration with Northern Michigan University on Sleep Research	09/02
TrivarX Secures R&D Tax Rebate for Fiscal Year 2023; Shares Fall 4%	08/02
Over Half of Patients On Track for Completion in TrivarX's SAMDE Study	07/02
TrivarX Undertaking 1-for-20 Securities Consolidation	18/10/23
Medibio Limited has Changed its Name to TrivarX Limited	06/10/23
Medibio Limited Announces Dr. Thomas Young Will Transition from His Role as Part-Time Chief Executive Officer to Non-Executive Director	06/10/23
Medibio Limited Announces Dr. Thomas Young Will Transition from His Role as Part-Time Chief Executive Officer to Non-Executive Director	06/10/23
Medibio Begins Phase Two Trial for Sleep Algorithm	04/09/23
TrivarX Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
Medibio Completes Phase One Depressive Episode Sleep Trial	24/07/23
US FDA Denies Breakthrough Device Designation for Medibio’s Depression Diagnostic Device	21/07/23
Medibio Completes Shares Purchase Plan	29/05/23
Medibio Adds Executive Director Role to CEO, Changes Principal Pace of Business	12/04/23
Medibio Limited Announces Board & Management Changes	12/04/23
Medibio Limited Announces Change of Registered Office and Principal Place of Business	12/04/23
Medibio Limited Announces Resignation of Matt Mesnik as Non-Executive Director	16/03/23
Medibio Limited Lodges Breakthrough Device Designation with FDA	26/02/23
TrivarX Limited Reports Earnings Results for the Half Year Ended December 31, 2022	24/02/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues TrivarX Limited

Actions

TRI

AU0000300196

Autres langues

Filtres